Funding
MRCG-2018–16
CYSTIC FIBROSIS, THORACIC, BROWN
S.M.S. received funding from the US Cystic Fibrosis Foundation to develop the COMBAT-CF trial (STICK10K0, STICK19K0). This work was funded in part by grants awarded by the Health Research Board (HRB-ILP-POR-2019–004), the Irish Thoracic Society (MRCG-2018–16 and MRCG-2014–6), the US Cystic Fibrosis Foundation (OGARA1710), Australian NHMRC 2020 Synergy grant (APP1183640), the Glenn Brown Memorial Grant 2017 (The Institute for Respiratory Health, Perth, Australia), the European Commission (EU-634486), Science Foundation Ireland (SSPC-2/PharM5, 13/TIDA/B2625, 14/TIDA/2438 and 15/TIDA/2977) and Enterprise Ireland Commercialisation Fund (CF-2017–0757-P). M.S. is supported by a fellowship from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 712949 (TECNIOspring PLUS) and from the Agency for Business Competitiveness of the Government of Catalonia. TECSPR18-1–0056.